Microenvironment for hiPSC-derived pacemaking cardiomyocytes
Grant Award Details
Grant Type:
Grant Number:
DISC2-10120
Investigator(s):
Disease Focus:
Human Stem Cell Use:
Award Value:
$2,042,438
Status:
Closed
Progress Reports
Reporting Period:
NCE #1
Reporting Period:
NCE #2
Grant Application Details
Application Title:
Microenvironment for hiPSC-derived pacemaking cardiomyocytes
Public Abstract:
Research Objective
This proposal investigates the effects of the microenvironment on the development and maintenance of pacemaking function in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes.
Impact
Pacemaking function of hiPSC-derived cardiomyocytes is lost over time. Sustainability of pacemaking function of these cells is critical for engineering an biopacemaker from the patient's own cells.
Major Proposed Activities
This proposal investigates the effects of the microenvironment on the development and maintenance of pacemaking function in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes.
Impact
Pacemaking function of hiPSC-derived cardiomyocytes is lost over time. Sustainability of pacemaking function of these cells is critical for engineering an biopacemaker from the patient's own cells.
Major Proposed Activities
- Determine the effects of matrix scaffolds on the differentiation and maintenance of pacemaking function in hiPSC-derived cardiomyocytes.
- Determine the appropriate hiPSC-derived cardiac cells to be subjected to the microenvironment for efficient yield of pacemaking hiPSC-derived cardiomyocytes.
- Induce vascularization in tissue constructs in small animals to sustain pacemaking tissue construct.
- Test sustainability of a functional pacemaking tissue construct in a small animal model.
Statement of Benefit to California:
Over 350,000 patients a year in the U.S. require an electronic pacemaker to restore their heart rhythm. The annual healthcare burden amounts to $20 billion. Repeated surgeries to replace battery and electrical parts generate additional costs and suffering for the patients. A biopacemaker engineered from human stem cell-derived pacemaking cells can overcome problems associated with electronics and improve the quality of life for the pacemaker recipient while reducing cumulative health care costs.
Publications
- Stem Cells (2019): Human induced pluripotent stem cell line with genetically encoded fluorescent voltage indicator generated via CRISPR for action potential assessment post-cardiogenesis. (PubMed: 31566285)
- Stem Cells (2020): An intrinsic, label-free signal for identifying stem cell-derived cardiomyocyte subtype. (PubMed: 31778240)
- Circ Arrhythm Electrophysiol (2021): Making Heads or Tails of the Large Mammalian Sinoatrial Node Micro-Organization. (PubMed: 34794338)
- Stem Cell Res (2020): NODAL inhibition promotes differentiation of pacemaker-like cardiomyocytes from human induced pluripotent stem cells. (PubMed: 33128951)
- Cell Rep (2023): The sinoatrial node extracellular matrix promotes pacemaker phenotype and protects automaticity in engineered heart tissues from cyclic strain. (PubMed: 38041810)